• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study Finds Respiratory Symptoms in Cats Fail to Predict Detected Pathogens

by
November 16, 2026
in Biology, Health
Reading Time: 6 mins read
0
Study Finds Respiratory Symptoms in Cats Fail to Predict Detected Pathogens

Study Finds Respiratory Symptoms in Cats Fail to Predict Detected Pathogens

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective study of client-owned felines presenting with respiratory illness and eye irritation has demonstrated that physical symptoms cannot reliably predict the underlying microbial infections detected through molecular testing. Conducted across veterinary clinical visits between 2018 and 2025 involving 285 cats, the investigation revealed that typical clinical signs such as sneezing, chronic rhinitis, conjunctivitis, and coughing or pneumonia showed no statistically significant correlation with the presence of the most frequently detected bacterial or viral agents. Researchers emphasized that because different pathogens responsible for nearly indistinguishable respiratory phenotypes require distinct therapeutic strategies, empirical treatment based strictly on observable symptoms carries inherent clinical challenges in feline practice.

The study population comprised 157 male and 128 female cats ranging in age from approximately one month to over twenty years, encompassing all standard life stages established under the International Cat Care classification framework, from kittens and juniors to senior and super senior cats. All included animals presented to a private veterinary clinic with clinical manifestations of conjunctivitis, upper airway inflammation, coughing, or lower respiratory tract involvement. For every subject, sterile cotton mucosal swabs were gathered across three distinct anatomical regions—the conjunctiva, nasal cavity, and oropharynx—regardless of the specific presenting complaints. These anatomical samples were subsequently pooled and processed together for total nucleic acid extraction to facilitate simultaneous molecular analysis.

Diagnostic laboratory procedures utilized quantitative real-time polymerase chain reaction assays, establishing a conservative analytical positivity cutoff of at least one thousand pathogen copies per milliliter of sample to reliably exclude incidental commensal carriage, transient contamination, or background baseline noise. Molecular profiling across the cohort identified Mycoplasma species as the dominant microbial group, detected in 121 of 258 tested felines, representing an overall detection rate of 46.9 percent. The emerging bacterial pathogen Filobacterium felis, formerly identified in literature as cilia-associated respiratory bacillus-like organisms, was identified in 59 of 138 tested animals, yielding a detection rate of 42.8 percent. Ureaplasma species were detected in 82 of 211 tested patients, accounting for 38.9 percent of the evaluated cohort.

In contrast to the high detection rates observed for Mycoplasma, Filobacterium, and Ureaplasma, classical respiratory pathogens were identified with notably lower frequency throughout the evaluated years. Feline herpesvirus type 1 was confirmed by molecular assays in 19 of 221 tested cats, reflecting an 8.6 percent detection rate, while Chlamydia species appeared in 11 of 253 tested cats, representing 4.3 percent. Bordetella bronchiseptica was documented in just one of 86 evaluated animals, corresponding to 1.2 percent, and feline calicivirus was not detected in any of the 86 cats subjected to targeted reverse transcription testing. The authors noted that high vaccination coverage reaching nearly 80 percent and the predominantly indoor lifestyle of the household cohort likely contributed to the absence of calicivirus.

Statistical evaluation demonstrated a marked dissociation between physical disease manifestations and the specific pathogens identified by molecular screening. Mycoplasma species occurred at essentially equivalent rates among cats exhibiting sneezing or rhinitis and those without these signs, showing 48 percent versus 46 percent positivity. Similarly, Mycoplasma was detected in 49 percent of cats presenting with conjunctivitis compared to 46 percent of unaffected animals, and in 48 percent of cats exhibiting cough or pneumonia compared to 46 percent without lower airway symptoms. Ureaplasma species exhibited comparable non-discriminatory distributions, being present in 35 percent of cats with sneezing versus 42 percent without, and 40 percent of cats with cough versus 38 percent without.

The sole clear exception to this pattern of non-specific presentation occurred with Chlamydia species, which displayed a statistically significant association with ocular disease. Cats presenting with conjunctivitis demonstrated a 13 percent detection frequency for Chlamydia, compared to only one percent among felines without ocular involvement, yielding a statistically significant difference with a p-value below 0.001. Conversely, Chlamydia was entirely absent among the 93 animals presenting with coughing or pneumonia, compared to seven percent of cats presenting without lower respiratory involvement. For Filobacterium felis, detection appeared in 49 percent of cats with rhinitis versus 36 percent without, although this numerical difference did not achieve formal statistical significance.

Poly-microbial detections represented a prominent characteristic within the standardized subset of 138 cats evaluated with a uniform five-pathogen panel between 2021 and 2025. Among this group, only 25 cats, or 18.1 percent, tested entirely negative for all panel targets, while single pathogens appeared in 51 cats, representing 37.0 percent. Notably, 62 animals, accounting for 44.9 percent of this sub-cohort, tested positive for two or more organisms concurrently, including 47 felines with dual infections and 15 felines harboring three distinct agents. While pairwise statistical comparisons revealed no significant mutual exclusion or obligate pairing between any two specific pathogens, Filobacterium felis was notably present in every observed triple-infection combination.

Therapeutic records revealed that veterinary practitioners utilized different drug classes depending on the dominant molecular target identified. First-line therapies for Mycoplasma and Ureaplasma infections relied primarily on fluoroquinolones, predominantly pradofloxacin, as well as tetracyclines such as doxycycline. In contrast, mono-infections involving Filobacterium felis were managed primarily using sulfonamide antimicrobials. Follow-up real-time polymerase chain reaction testing documented negative post-treatment results across subsets of cats treated for Mycoplasma, Ureaplasma, and Filobacterium felis infections. However, the researchers emphasized that the retrospective framework, variable follow-up testing compliance among pet owners, and frequent empirical adjustments prevented definitive comparisons regarding the relative clinical efficacy of specific antimicrobial regimens.

The study authors highlighted several methodological boundaries that must contextualize their findings, most notably the retrospective single-clinic design, the lack of an asymptomatic healthy control group, and the pooling of anatomical swabs. Because organisms such as Mycoplasma and Ureaplasma can inhabit mucosal surfaces as commensals or resident microbiota, positive molecular detection does not inherently establish primary disease causation. Nevertheless, because bacterial targets such as Filobacterium felis display therapeutic requirements that differ substantially from standard empirical treatments, the authors concluded that quantitative real-time PCR provides critical clinical information when managing persistent, recurrent, or non-responsive feline respiratory cases.

Beyond initial diagnostic screening, the clinical workflow incorporated a tiered management protocol determined by patient vulnerability and disease severity. In feline patients presenting with severe manifestations, lower airway involvement, or heightened physiologic vulnerability, including very young kittens, geriatric animals, or immunocompromised individuals, veterinary clinicians instituted immediate empirical therapy consisting of supportive interventions, broad-spectrum antimicrobials, or targeted antiviral coverage with famciclovir. Conversely, for cats exhibiting mild, non-life-threatening upper respiratory or ocular presentations, empirical antimicrobial administration was withheld in favor of supportive care and close observation while awaiting molecular findings. Among the twenty-five cats that tested negative across the entire standardized five-pathogen panel, clinical resolution occurred uniformly. Seven of these panel-negative felines received tailored or empirical medications based on lower-threshold molecular signals or clinical risk, including antiviral therapy for herpesvirus-like illness, while the remaining eighteen patients experienced spontaneous clinical resolution without pharmaceutical intervention.

Detailed records from subsequent treatment phases revealed additional nuance regarding pathogen clearance and multi-agent combinations. When initial therapeutic choices failed to eliminate molecular positivity, secondary antimicrobial courses demonstrated favorable microbiological outcomes upon follow-up testing. Among nine cats receiving second-line therapy for persistent Mycoplasma detections, five underwent repeated testing, yielding four negative results and one persistent positive. For Ureaplasma infections, seventeen cats required second-line therapy, with fifteen completing follow-up testing that confirmed fourteen negative outcomes and a single unresolved case. Four cats received secondary regimens for Filobacterium felis, with the sole retested patient achieving documented molecular clearance. Furthermore, among the fifteen felines harboring simultaneous triple infections, specific combinations emerged: nine individuals carried Mycoplasma, Ureaplasma, and Filobacterium felis; four cats harbored Ureaplasma, feline herpesvirus type 1, and Filobacterium felis; and two patients exhibited concurrent Mycoplasma, feline herpesvirus type 1, and Filobacterium felis.

Understanding these clinical patterns requires examining the biological characteristics of the underlying organisms. Mycoplasmas are distinctive cell wall-deficient bacteria possessing diminutive genomes and restricted metabolic capabilities that render them intimately dependent on host tissues. Decades of veterinary investigation have demonstrated that interpreting their recovery depends heavily on anatomical site and specific taxonomy, with certain species inhabiting healthy mucosal surfaces while others associate with clinical inflammation. Similarly, feline ureaplasmas, historically classified into species such as Ureaplasma felinum and Ureaplasma cati, have long been recognized in oral secretions and occasionally lower airways, though definitive evidence establishing primary pathogenicity remains sparse. In human medicine, human-associated ureaplasmas are recognized contributors to conditions such as bronchopulmonary dysplasia in preterm infants and hyperammonemia syndrome following lung transplantation, but the source data confirm that feline-associated ureaplasmas have not demonstrated zoonotic transmission to humans.

The investigation also built upon emerging literature regarding Filobacterium felis, an organism related to cilia-associated respiratory bacilli originally characterized as chronic respiratory pathogens in laboratory rodents. Filamentous bacteria colonizing ciliated bronchial epithelium were first described in feline post-mortem specimens, leading to subsequent molecular isolation in domestic cats suffering from chronic lower respiratory disease characterized by neutrophilic and histiocytic inflammation. Earlier interventional reports documented that targeted administration of trimethoprim-sulfamethoxazole over a six-week course achieved lasting resolution in affected felines, establishing a precedent for sulfonamide therapy that contrasts sharply with standard feline respiratory prescriptions. To advance diagnostic precision, the authors recommended that future prospective investigations incorporate healthy control groups, quantitative load evaluations, site-specific mucosal sampling, and species-level molecular discrimination to distinguish opportunistic colonization from active clinical disease.

Subject of Research: Diagnostic pathogen detection and clinical associations in feline respiratory disease

Article Title: Targeted diagnosis and treatment of respiratory disease in cats: clinical findings, pathogen detection, and outcomes in a retrospective study

Article References: Naceradska, M., Kollarova, N., Hruška, M., Pekova, S., Jelen, S., & Fridrichová, M. (2026). Targeted diagnosis and treatment of respiratory disease in cats: clinical findings, pathogen detection, and outcomes in a retrospective study. Frontiers in Veterinary Science, 13, 1989169. https://doi.org/10.3389/fvets.2026.1989169

Image Credits: AI Generated

DOI: 10.3389/fvets.2026.1989169

Keywords: feline respiratory disease, veterinary medicine, Mycoplasma felis, Filobacterium felis, Ureaplasma, Chlamydia felis, feline herpesvirus, real-time PCR, molecular diagnostics, antimicrobial stewardship, veterinary infectious diseases, conjunctivitis in cats, polymicrobial infections, respiratory pathogens, rhinitis in cats

News Source: William Thompson. (November 16, 2026). Study Finds Respiratory Symptoms in Cats Fail to Predict Detected Pathogens. Scienmag.

Tags: Antimicrobial StewardshipChlamydia felisconjunctivitis in catsfeline herpesvirusfeline respiratory diseaseFilobacterium felisMolecular diagnosticsMycoplasma felisPolymicrobial infectionsreal-time PCRrespiratory pathogensrhinitis in catsUreaplasmaVeterinary Infectious Diseasesveterinary medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

High-Volume Nerve Block Aids Patient Positioning for Acetabular Fracture Spinal Anesthesia

High-Volume Nerve Block Aids Patient Positioning for Acetabular Fracture Spinal Anesthesia

November 20, 2026
Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

November 20, 2026

Blood Ratio Combining Clotting and Kidney Markers Tracks Gout Severity

November 20, 2026

Physical Activity Not Linked to Colon Cancer Tumor Immune Infiltration

November 20, 2026

POPULAR NEWS

  • Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    29 shares
    Share 12 Tweet 7
  • Narrative Review Integrates Imaging, Biomechanics, and Movement in Lumbar Spondylolysis

    29 shares
    Share 12 Tweet 7
  • Bifrontal Brain Stimulation Improves Working Memory in Schizophrenia Without Sex Differences

    29 shares
    Share 12 Tweet 7
  • Robotic and Conventional Knee Replacements Show Comparable One-Year Joint Infection Rates

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

High-Volume Nerve Block Aids Patient Positioning for Acetabular Fracture Spinal Anesthesia

Researchers Extend Positive Geometries to Branch Cuts and String Scattering Amplitudes

Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.